News Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI Artificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of technology for drug discovery.
News Kyowa Kirin to expand UK headquarters despite Brexit Other Japanese firms could scale back UK investment.
News GSK plans $800m US manufacturing investment GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.